Modified CadA Enzyme Alkaline pH Stability

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Acid decarboxylases, such as CadA, have limited functional stability and activity outside a narrow pH range, leading to decreased performance and increased salt production in biochemical processes, which complicates the conversion of lysine to cadaverine and results in higher operational costs and environmental impact.

Innovation Solution

A CadA variant polypeptide with specific amino acid substitutions at glutamic acid residues, allowing the enzyme to maintain stability and activity across a wider pH range, reducing the need for pH adjustment chemicals and minimizing salt production.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If wild-type CadA enzyme is used, then the enzyme functions optimally at pH 5.0-5.5, but the enzyme activity decreases significantly outside this narrow pH range

Engineering Contradiction:
Improveenzyme activity stabilityVSAvoidpH range tolerance
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent applies parameter changes by modifying the amino acid sequence of the CadA enzyme through site-directed mutagenesis. Specific residues (Asp283, Glu291, Asp353, Glu355, Asp461, Glu463, Asp468, Glu482, Asp499) are mutated to alter the enzyme's isoelectric point and charge distribution, enabling it to maintain stability and activity across a broader pH range (pH 6.0-8.0) while preserving its decarboxylase function.

Inventive Principle:
Principle #35Parameter changes

2Productivity

If pH adjustment chemicals are added to maintain optimal pH, then enzyme activity is maintained, but salt production increases and environmental impact worsens

Engineering Contradiction:
Improveconversion rateVSAvoidsalt waste
Core Design Contradiction:
ProductivityVSObject-generated harmful factors

Solution Approach 1:

The patent implements self-service by engineering the CadA enzyme to autonomously maintain its catalytic activity across a broader pH range without requiring external pH adjustment chemicals. The mutated enzyme adapts to the natural pH conditions of the fermentation medium, eliminating the need for acid or base additions and thereby preventing salt waste generation from neutralization reactions.

Inventive Principle:
Principle #25Self-service

3Reliability

If higher molecular weight protein complexes form, then enzyme function is optimized, but inhibition of complex formation significantly decreases function

Engineering Contradiction:
Improveenzyme functionVSAvoidquaternary structure stability
Core Design Contradiction:
ReliabilityVSStability of the object's composition

Solution Approach 1:

The patent applies parameter changes by mutating surface-exposed residues in the CadA enzyme that are involved in quaternary structure formation and stability. These mutations (particularly at positions 283, 291, 353, 355, 461, 463, 468, 482, and 499) modify the electrostatic interactions and hydrogen bonding networks that stabilize higher-order oligomeric complexes, enabling the enzyme to maintain functional quaternary structures under alkaline pH conditions where wild-type enzymes would dissociate or become inactive.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The variant CadA polypeptide enhances the conversion of lysine to cadaverine at alkaline pH, improving reaction rates and reducing the environmental footprint and costs associated with salt waste, while maintaining high production yields.

Implementation Method 1

A CadA variant polypeptide with specific amino acid substitutions at glutamic acid residues, allowing the enzyme to maintain stability and activity across a wider pH range

Methodology Applied
Scientific EffectEnzyme catalysis: Enzyme

Implementation Method 2

the conversion of lysine to cadaverine

Methodology Applied
Scientific EffectDecarboxylation reaction:

Data Source

PatentUS11041177B2Modified lysine decarboxylase enzymes
Publication Date: 2021.06.22 CIBT AMERICA INC
  • US11041177B2 patent drawing
  • US11041177B2 patent drawing

AI summary

The invention provides CadA polypeptides with mutations that increase activity in alkaline pH compared to the wild-type lysine decarboxylase. The invention also provides methods of generating such mutant polypeptides, microorganisms genetically modified to overexpress the mutant polypeptides, and methods of generating such microorganism.